The recommendations, published June 18 in JAMA, replace the task force’s 2017 guidance that recommended providers screen children for obesity. The task force considers the guidance a B recommendation, indicating a high degree of certainty of moderate benefits and requiring most private health insurance plans to cover treatment without a copay.
The updated recommendations do not include prescribing GLP-1 drugs.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
